Kuros Biosciences' Dutch Unit In Deal To Supply Bone Graft To SeaSpine

(RTTNews) - Kuros Biosciences, a developer of innovative products for tissue repair and regeneration, announced Monday that its Dutch subsidiary, Kuros Biosciences BV, has signed a private label Original Equipment Manufacturer or OEM agreement with medical technology company SeaSpine Holdings Corp. (SPNE). Terms of the agreement were not disclosed.

Under the agreement, Kuros will supply the bone graft in various forms and SeaSpine will market the products under the brand name OsteoCurrent in the U.S. and other select markets in Europe, South America and the Middle East providing the necessary regulatory approvals are achieved.

Initial sales in the U.S. are expected prior to the end of H1 2019.

Kuros's proprietary bone graft technology comprises biphasic calcium phosphate with an advanced submicron surface topography that directs bone formation after implantation.